4th Quarter - Report

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
$190,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Support repeal of medical device tax.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Address concerns with provisions of patent litigation reform, including inter partes review. Educate on Bayh-Dole Act "march-in" provision.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

FDA review process consistency and predictability. Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs. Support the Strengthening Public Health Emergency Response Act.Support the Strengthening Public Health Emergency Response Act

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs, and Hospital Outpatient Prospective Payment System. Address concerns with Medicaid coverage of specialty drugs. Support creation of incentives for antibiotics development. Oppose changes to Medicare Advantage and Part D prescription drug benefit. Support the Ensuring Patient Access to Critical Breakthrough Products Act. Support Medicare Continuous Glucose Monitor Access Act. Support the Ensuring Patient Access to Critical Breakthrough Products Act. Support Medicare Continuous Glucose Monitor Access Act

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation;FDA Appropriations; PTO Appropriations.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Support NIH research funding. Support Rare Disease Priority Review Voucher permanent extension. Support reforms to reduce administrative & regulatory burdens on scientific productivity, innovation & collaboration. Support reforms to support & evolve the scientific workforce continuum. Support 21st Century Cures Act. Support Removing Barriers to Clinical Research Act. Support Advancing Breakthrough Medical Devices for Patients Act. Support Innovation for Healthier Americans initiative.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.